Basel, October 29, 2024 – Novartis announced today that Scemblix ® (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients with newly diagnosed ...
26, when the U.S. Food and Drug Administration (FDA ... and tended to lessen with time. The label also alerts patients that the drug is associated with urinary retention, increased heart rate and ...